Ebola Drugs a Low Priority for Pharmaceutical Companies

Written by Pat Papers | Wednesday, 6 August 2014 8:47 AM


While the world experiences the deadliest Ebola outbreak ever, the disease remains one that has no drugs to treat it. The San Francisco Chronicle says drug makers have little incentive to spend time and money on a disease that predominantly affects people in impoverished countries. Health officials tell the Chronicle this outbreak could encourage pharmaceutical companies to speed up the development process or lead small groups in risky drug trials.

SOURCE: San Francisco Chronicle

Share This Story

Tracker Pixel for Entry
 

 

Now in Bookstores

Good Morning City

Good Morning City

Pat’s picture book is a perfect gift for anyone between the ages of 2 and 6.



Listen and Subscribe

Pat and Jamie Podcast

Pat and Jamie Podcast

Pat Kiernan and Jamie Stelter talk to New Yorkers about New York. Online and Live at 92Y.

calendar

From the Pat's Papers Archive: Today in History

February 24, 2016

Favorites

News

U.S. Newspapers

International Newspapers